Pluronic F-127 Gels as a NOvel Vehicle for Rectal Administration of Indomethacin

Polyoxyethylene-polyoxypropylene surface-active block copolymers (Pluronics(R)) were evaluated as a vehicle for rectal administration of indomethacin.The effects of the concentration of Pluronic F-127, temperature, and drug concentration on the drug release were studied by means of an in vitro relea...

Full description

Saved in:
Bibliographic Details
Published inChemical & pharmaceutical bulletin Vol. 34; no. 4; pp. 1801 - 1808
Main Authors MIYAZAKI, SHOZO, YOKOUCHI, CHIZUKO, NAKAMURA, TSUGUYA, HASHIGUCHI, NORIO, HOU, WEI-MIN, TAKADA, MASAHIKO
Format Journal Article
LanguageEnglish
Published Tokyo The Pharmaceutical Society of Japan 1986
Maruzen
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Polyoxyethylene-polyoxypropylene surface-active block copolymers (Pluronics(R)) were evaluated as a vehicle for rectal administration of indomethacin.The effects of the concentration of Pluronic F-127, temperature, and drug concentration on the drug release were studied by means of an in vitro release method using a cellulose membrane. With increasing concentration of Pluronic F-127 in the vehicle, a corresponding decrease in the apparent release rate of the drug occurred. The apparent release rate increased with increasing temperature from 20 to 44°C. Increase in drug concentration increased the drug release rate.Indomethacin gel preparations made by dissolving the drug in Pluronic F-127 aqueous gel were administered rectally to rabbits and the drug plasma levels were compared with those after rectal administration of commercial suppositories. When a commercial suppository was given to rabbits, the plasma concentration reached the maximum level 30 min after administration. On the other hand, the gel preparation did not show a sharp peak of plasma concentration and produced a sustained plateau level of indomethacin from 15 min to 10 h without a lag time.Thus, it appeared that indomethacin preparations based on Pluronic F-127 aqueous gel may be practically useful as a rectal preparation with prolonged action and with reduced side effects.
AbstractList Polyoxyethylene-polyoxypropylene surface-active block copolymers (Pluronics(R)) were evaluated as a vehicle for rectal administration of indomethacin.The effects of the concentration of Pluronic F-127, temperature, and drug concentration on the drug release were studied by means of an in vitro release method using a cellulose membrane. With increasing concentration of Pluronic F-127 in the vehicle, a corresponding decrease in the apparent release rate of the drug occurred. The apparent release rate increased with increasing temperature from 20 to 44°C. Increase in drug concentration increased the drug release rate.Indomethacin gel preparations made by dissolving the drug in Pluronic F-127 aqueous gel were administered rectally to rabbits and the drug plasma levels were compared with those after rectal administration of commercial suppositories. When a commercial suppository was given to rabbits, the plasma concentration reached the maximum level 30 min after administration. On the other hand, the gel preparation did not show a sharp peak of plasma concentration and produced a sustained plateau level of indomethacin from 15 min to 10 h without a lag time.Thus, it appeared that indomethacin preparations based on Pluronic F-127 aqueous gel may be practically useful as a rectal preparation with prolonged action and with reduced side effects.
Author HASHIGUCHI, NORIO
NAKAMURA, TSUGUYA
TAKADA, MASAHIKO
YOKOUCHI, CHIZUKO
HOU, WEI-MIN
MIYAZAKI, SHOZO
Author_xml – sequence: 1
  fullname: MIYAZAKI, SHOZO
– sequence: 2
  fullname: YOKOUCHI, CHIZUKO
– sequence: 3
  fullname: NAKAMURA, TSUGUYA
– sequence: 4
  fullname: HASHIGUCHI, NORIO
– sequence: 5
  fullname: HOU, WEI-MIN
– sequence: 6
  fullname: TAKADA, MASAHIKO
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8015150$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/3719880$$D View this record in MEDLINE/PubMed
BookMark eNpFkM1rHCEchiWkpJuPU84FDyWXMlu_ZtRjyFcDoQkl7VVc52fW4OhWZwv97zvDLlsQPbwP7yvPKTpOOQFCl5QsKRPqq9usllwsqSL0CC0oF7JpGePHaEEI0Q3jHf-ITmt9J4S1RPITdMIl1UqRBXp5iduSU3D4vqFM4geIFdvp4O_PfyDiX7AOLgL2ueAf4EYb8XU_hBTqWOwYcsLZ48fU5wHGtXUhnaMP3sYKF_v3DP28v3u9-dY8PT883lw_NU5oTpu2l5yA8moFrQbhmVed1kCm73W-E1pq7wjrQNkVo7LvuFBU0r5lPZHadZSfoatd76bk31uooxlCdRCjTZC31chO6UnFDH7Zga7kWgt4sylhsOWvocTM_szkz3BhZn8T_Wlfu10N0B_YvbAp_7zPbXU2-mKTC_WATRUtbWfsdoe919G-wSG3ZZx1zpNUt2qeFbtrXv8fr20xkPg_W2aO3w
CODEN CPBTAL
CitedBy_id crossref_primary_10_3390_pharmaceutics14102210
crossref_primary_10_1016_S0378_5173_97_00209_3
crossref_primary_10_1016_0168_3659_89_90034_5
crossref_primary_10_1007_s10924_011_0290_8
crossref_primary_10_1016_S0378_5173_99_00119_2
crossref_primary_10_1021_bm020066h
crossref_primary_10_1152_ajpgi_00065_2006
crossref_primary_10_1177_0091270009344984
crossref_primary_10_1016_S0378_5173_99_00090_3
crossref_primary_10_1007_s40005_015_0174_3
crossref_primary_10_1016_S0378_5173_97_00276_7
crossref_primary_10_1089_ten_2004_10_1566
crossref_primary_10_1016_0378_5173_92_90269_8
crossref_primary_10_1080_01932691003659684
crossref_primary_10_33483_jfpau_1154051
crossref_primary_10_1177_0091270010378859
crossref_primary_10_1016_j_colsurfb_2018_12_068
crossref_primary_10_1111_j_2042_7158_1995_tb05829_x
crossref_primary_10_1080_03639040801926030
crossref_primary_10_1006_jcis_1997_4880
crossref_primary_10_3109_03639049809085634
crossref_primary_10_3109_03639049409049337
crossref_primary_10_1002_jps_2600800318
crossref_primary_10_1016_S0378_5173_99_00026_5
crossref_primary_10_1007_s13318_016_0369_7
crossref_primary_10_1111_j_2042_7158_1988_tb05325_x
crossref_primary_10_3390_pharmaceutics11090445
crossref_primary_10_1016_S0168_3659_98_00079_0
crossref_primary_10_1007_s10856_012_4564_z
crossref_primary_10_1016_j_ijpharm_2005_04_023
crossref_primary_10_1016_S0169_7439_02_00045_X
crossref_primary_10_1095_biolreprod_103_019182
crossref_primary_10_1211_0022357011776621
crossref_primary_10_1016_S0378_5173_02_00394_0
crossref_primary_10_1021_ma010562i
crossref_primary_10_1016_j_ijpharm_2004_03_029
crossref_primary_10_1039_C5RA15006J
crossref_primary_10_1080_01932690600991755
crossref_primary_10_3390_cancers13164032
crossref_primary_10_1016_j_colsurfb_2013_10_030
crossref_primary_10_1016_j_colsurfb_2007_12_009
crossref_primary_10_1016_S1773_2247_11_50080_2
crossref_primary_10_1080_10717540050120188
crossref_primary_10_1081_DDC_100102171
crossref_primary_10_1016_j_addr_2014_05_012
crossref_primary_10_1590_S0104_14281999000200012
crossref_primary_10_1016_S0378_5173_99_00366_X
crossref_primary_10_1002_jbm_a_30505
crossref_primary_10_1016_j_ijpharm_2009_05_047
crossref_primary_10_1080_01932699608943525
crossref_primary_10_1016_0378_5173_91_90174_M
crossref_primary_10_1007_s11746_997_0119_8
crossref_primary_10_1088_0964_1726_23_2_025012
crossref_primary_10_1007_s12257_017_0162_8
crossref_primary_10_1016_j_colsurfb_2007_07_002
crossref_primary_10_3109_03639049709149826
ContentType Journal Article
Copyright The Pharmaceutical Society of Japan
1987 INIST-CNRS
Copyright_xml – notice: The Pharmaceutical Society of Japan
– notice: 1987 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1248/cpb.34.1801
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1347-5223
EndPage 1808
ExternalDocumentID 10_1248_cpb_34_1801
3719880
8015150
article_cpb1958_34_4_34_4_1801_article_char_en
Genre Journal Article
GroupedDBID ---
.55
.GJ
2WC
53G
5GY
6J9
AAUGY
ACGFO
ACIWK
ACPRK
ADBBV
AENEX
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
EBS
EJD
F5P
GX1
HH5
JSF
JSH
KQ8
L7B
OK1
P2P
RJT
RZJ
TKC
TR2
VH1
X7M
ZGI
29B
3O-
AABQG
ABTAH
BKOMP
E3Z
IQODW
JMI
MOJWN
X7J
XSB
ZE2
ZY4
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c4931-5d730e8f8be59e4f2f8699e00736f64979fc026e8ab217d6348171d52d079c613
ISSN 0009-2363
IngestDate Fri Aug 16 14:02:51 EDT 2024
Fri Aug 23 02:37:02 EDT 2024
Sat Sep 28 08:35:12 EDT 2024
Sun Oct 29 17:10:09 EDT 2023
Thu Aug 17 20:29:16 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Rectal form
Controlled release form
Wetting agent
Vehicle(excipient)
Rabbit
Lagomorpha
Property formulation relationship
Non steroidal antiinflammatory agent
Ethylene oxide polymer
Colloidal gel
Vertebrata
Mammalia
Absorption
Animal
Propylene oxide polymer
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4931-5d730e8f8be59e4f2f8699e00736f64979fc026e8ab217d6348171d52d079c613
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/cpb1958/34/4/34_4_1801/_article/-char/en
PMID 3719880
PQID 76891341
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_76891341
crossref_primary_10_1248_cpb_34_1801
pubmed_primary_3719880
pascalfrancis_primary_8015150
jstage_primary_article_cpb1958_34_4_34_4_1801_article_char_en
PublicationCentury 1900
PublicationDate 1986-00-00
PublicationDateYYYYMMDD 1986-01-01
PublicationDate_xml – year: 1986
  text: 1986-00-00
PublicationDecade 1980
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Chemical & pharmaceutical bulletin
PublicationTitleAlternate Chem. Pharm. Bull.
PublicationYear 1986
Publisher The Pharmaceutical Society of Japan
Maruzen
Publisher_xml – name: The Pharmaceutical Society of Japan
– name: Maruzen
References 2) This work was presented at the 105th Annual Meeting of the Pharmaceutical Society of Japan, Kanazawa, April 1985.
1) Pharmaceutical Application of Biomedical Polymers, Part XX. Part XIX: S. Miyazaki, N. Hashiguchi, W.-M. Hou, C. Yokouchi, and M. Takada, Chem. Pharm. Bull., in press.
9) S. C. Miller and M. D. Donovan, Int. J. Pharm., 12, 147 (1982).
15) S. Muranishi, Y. Okubo, and H. Sezaki, Yakuzaigaku, 39, 1 (1979).
17) M. Vadnere, G. Anudon, S. Lindenbaum, and J. L. Haslam, Int. J. Pharm., 22, 207 (1984).
24) T. Inukai, H. Awata, H. Kurokawa, M. Adachi, Y. Nakanishi, and Y. Nagao, Yakuri To Chiryo, 7, 21 (1979).
13) A. G. Boer, F. Moolenaar, L. G. J. Heede, and D. D. Breimer, Clin. Pharmacokinet., 7, 285 (1982).
22) H. Bechgaard, R. R. Brodie, L. F. Chasseaud, P. Houmoller, J. O. Hunter, P. Siklos, and T. Taylor, Eur. J. Clin. Pharmacol., 21, 511 (1982).
27) P. A. Swispner, S. L. Sendelbeck, and J. W. Fara, Int. J. Pharm., 22, 219 (1984).
12) L. P. J. Holt and C. F. Haukins, Br. Med. J., 1, 1354 (1965).
4) I. R. Schmolka, J. Am. Oil Chem. Soc., 54, 110 (1977).
26) K. Park and R. Robinson, Int. J. Pharm., 19, 107 (1984).
20) J. Rassing and D. Attwood, Int. J. Pharm., 13, 47 (1983).
3) Present address: Department of Dosage Form, Shanghai Institute of Pharmaceutical Industry, 1320 Beijing Road West, Shanghai, China.
7) H. P. Gregor, H. T. Hsia, S. Palevsky, R. S. Neuwirth, and R. M. Richart, "Controlled Release Polymeric Formulations,"
25) S. Kondo, Kiso To Rinsho, 18, 494 (1984).
21) W. A. Ritschel, "Handbook of Basic Pharmacokinetics," Drug Intelligence Publications, Hamilton, 1976, pp. 235-243.
10) S. Miyazaki, S. Takeuchi, C. Yokouchi, and M. Takada, Chem. Pharm. Bull., 32, 4205 (1984).
28) T. Kamano, H. Kishino, K. Mizukami, N. Azuma, K. Kondo, Y. Watanabe, and T. Kidokoro, Gan To Kagaku Ryoho, 9, 1394 (1982).
18) S. C. Miller and B. R. Drabik, Int. J. Pharm., 18, 269 (1984).
6) Asahi Denka Kogyo Co., PLURONIC and TETRONIC, Publication No. 04'81-1.
23) G. Alvan, M. Orme, L. Bertelsson, R. Ekstraud, and L. Palmer, Clin. Pharmacol. Ther., 18, 364 (1975).
ed. by D. R. Paul and F. W. Harris, American Chemical Society, Washington D.C., 1976, pp. 147-156.
8) P. C. Chew-Chow and S. G. Frank, Int. J. Pharm., 8, 89 (1981).
16) G. G. Skellern and E. G. Salole, J. Chromatogr., 114, 483 (1975).
19) G. L. Flynn, S. H. Yalkowsky, and J. J. Roseman, J. Pharm. Sci., 63, 479 (1974).
11) L. Helleberg, Chin. Pharmacokinet., 6, 245 (1981).
14) T. Umeda, A. Matsuzawa, T. Yokoyama, K. Kuroda, and T. Kuroda, Chem. Pharm. Bull., 31, 2793 (1983).
5) I. R. Schmolka, J. Biomed. Mater. Res., 6, 571 (1972).
References_xml
SSID ssj0025073
Score 1.496158
Snippet Polyoxyethylene-polyoxypropylene surface-active block copolymers (Pluronics(R)) were evaluated as a vehicle for rectal administration of indomethacin.The...
SourceID proquest
crossref
pubmed
pascalfrancis
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 1801
SubjectTerms Animals
Biological and medical sciences
Gels
General pharmacology
Indomethacin - administration & dosage
Indomethacin - blood
Male
Medical sciences
Pharmaceutical technology. Pharmaceutical industry
Pharmaceutical Vehicles
Pharmacology. Drug treatments
Poloxalene
Polyethylene Glycols
Rabbits
rectal delivery system
Suppositories
Title Pluronic F-127 Gels as a NOvel Vehicle for Rectal Administration of Indomethacin
URI https://www.jstage.jst.go.jp/article/cpb1958/34/4/34_4_1801/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/3719880
https://search.proquest.com/docview/76891341
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Chemical and Pharmaceutical Bulletin, 1986/04/25, Vol.34(4), pp.1801-1808
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELeqwQMSQnxNFBj4YdpLl9IkzocfeIgmRku1rkArbbxETmJvoCmt1nZS99dzFztfaIgPqYra1HZa389n3_nuZ0L2XSnA2EmEFSjuWywIuSXsAQhEZQNfMiV9gf6Ok4k_nLNPZ95Zp7NtRC1t1kk_vb0zr-R_pAr3QK6YJfsPkq0ahRvwHuQLV5AwXP9KxtOrjT7B5tiynaB3AfMcnhsjevniRl71buQl1igiCVGxIS1AiytX80VkCzxGWqSGg7ukLSiZBBAby8uW5ztpcnajtEbn0bdoPGq5Us9Px6fzo-Go5YqdROPoZP4laoVnD6Ovw9HHsuykdkTY3BBYF2FI4npzaxLXSjXLLcc1mktqzeqyAKxenVxcql7jx_ze9CsUetQOjYtDlh_DO_W9wzCHIV0mfZf160pNVu1fZrsqBhEKe4W3554DOgqjQcefqw0oWBgG1SF8-E9Maic8713jaa3FzP0fsJ5HooaHS7ECYSh9MsrvTZdiCTN7TB4Z24NGGkhPSEfmT8nBVMt2e0hndS7e6pAe0GlNa759RqYl2miBNopoowJetEAbNWijgDaq0UbbaKMLRZtoe07mxx9mR0PLnMdhpYy7tuVlMB3IUIWJ9DiMY0eFPucSN3t95TMecJWCSS9DkYChm_mY4x3Ymedkg4CnsG7cJTv5IpcvCFVKSKlEJt3AZSlXUDP1ZOoOEsfJbGF3yX7ZsfFS067EaK5C_8fQ_7HLYuz_LnmvO70qZMYiFkIaJSzI9AXL119DB4IG6ZK9lqyqZgw4uuRtKbsY1C7upYlcLjarGKx0jFmBX7CrRVpVdQMYHOHg5R-afkUe4CDS3rzXZGd9vZF7sL5dJ28KJP4ELVuk7Q
link.rule.ids 315,783,787,4031,27935,27936,27937
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pluronic+F-127+gels+as+a+novel+vehicle+for+rectal+administration+of+indomethacin&rft.jtitle=Chemical+%26+pharmaceutical+bulletin&rft.au=MIYAZAKI%2C+S&rft.au=YOKOUCHI%2C+C&rft.au=NAKAMURA%2C+T&rft.au=HASHIGUCHI%2C+N&rft.date=1986&rft.pub=Maruzen&rft.issn=0009-2363&rft.eissn=1347-5223&rft.volume=34&rft.issue=4&rft.spage=1801&rft.epage=1808&rft_id=info:doi/10.1248%2Fcpb.34.1801&rft.externalDBID=n%2Fa&rft.externalDocID=8015150
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon